About this Research Topic
In this Research Topic, we will focus on studies that tackle the most recent advances in diagnosing and treating breast cancer using neoadjuvant systemic therapy. The focus is on new biomarkers and targeted therapies, including immunotherapy. Apart from tumor molecular characteristics, we will also cover the patient’s genetics and metabolism.
This collection will include Original Research papers and Review Articles.
Manuscripts should focus on:
- The clinical effects of neoadjuvant therapy on different breast cancer intrinsic subtypes; new treatment options
- Post-neoadjuvant treatment strategies for patients with residual or progressive disease
- Molecular characterization of primary and residual tumors
- Neoadjuvant chemotherapy in patients with underlying genetic abnormalities or metabolic dysfunction
- New neoadjuvant treatment strategies
- Advances in neoadjuvant clinical trial’s design
Keywords: Breast cancer, Neoadjuvant Chemotherapy, Luminal subtypes, HER-2, biomarkers, Post-neoadjuvant, Primary resistance
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.